PP2A Inactivation Mediated by PPP2R4 Haploinsufficiency Promotes Cancer Development
Published version of a preprint
Abstract
Abstract Protein phosphatase 2A (PP2A) complexes counteract many oncogenic kinase pathways. In cancer cells, PP2A function can be compromised by several mechanisms, including sporadic mutations in its scaffolding A and regulatory B subunits or more frequently through overexpression of cellular PP2A inhibitors. Here, we identify a novel genetic mechanism by which PP2A function is recurrently affected in human cancer, involving haploinsufficiency of PPP2R4, a gene encoding the cellular PP2A activator PTPA. Notably, up to 70% of cancer patients showed a heterozygous deletion or missense mutations in PPP2R4. Cancer-associated PTPA mutants exhibited decreased abilities to bind the PP2A-C subunit or activate PP2A and failed to reverse the tumorigenic phenotype induced by PTPA suppression, indicating they function as null alleles. In Ppp2r4 gene-trapped (gt) mice showing residual PTPA expression, total PP2A activity and methylation were reduced, selectively affecting specific PP2A holoenzymes. Both PTPAgt/gt and PTPA+/gt mice showed higher rates of spontaneous tumors, mainly hematologic malignancies and hepatocellular adenomas and carcinomas. These tumors exhibited increased c-Myc phosphorylation and increased Wnt or Hedgehog signaling. We observed a significant reduction in lifespan in PTPA+/gt mice compared with wild-type mice. In addition, chemical-induced skin carcinogenesis was accelerated in PTPA+/gt compared with wild-type mice. Our results provide evidence for PPP2R4 as a haploinsufficient tumor suppressor gene, defining a high-penetrance genetic mechanism for PP2A inhibition in human cancer. Cancer Res; 77(24); 6825–37. ©2017 AACR.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Homozygously targeted Ppp2r4 knockout mice (hypomorphic allele) with severely affected PTPA expression (on average only 20% of wild-type levels in most tissues) were born at less than Mendelian ratios, suggestive of embryonic lethality.
“For instance, homozygously targeted Ppp2r4 KO mice (hypomorphic allele), with severely affected expression of the PP2A activator PTPA (Phosphatase Two A Phosphatase Activator) (on average only 20% of WT levels were left in most tissues), were born at less than Mendelian ratios, suggestive for embryonic lethality [43].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [43]
A selective decrease in PP2A-B56γ/ε activity was found in PTPA knockout, while PP2A-B55 activity was unaffected.
“Interestingly, however, a selective decrease in PP2A-B56γ/ε activity was found, while PP2A-B55 activity was unaffected.”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [43]
In surviving PTPA knockout mice, overall PP2A-C methylation and activity were significantly reduced (50%).
“In the surviving PTPA KO mice, overall PP2A-C methylation and activity were significantly reduced (50%).”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [43]
In Ppp2r4 gt/+ mice, overall survival is decreased.
“-Embryonic lethality suggested; decreased overall survival in gt/+ mice [43]”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [43]
Accelerated DMBA/TPA-induced skin papillomas are also observed in heterozygous PTPA knockout mice, in which PP2A-B56γ/ε activity is selectively decreased.
“Notably, accelerated occurrence of DMBA/TPA-induced skin papillomas was also observed in heterozygous PTPA KO mice, in which activity of PP2A-B56γ/ε (and presumably other PP2A-B56 isoforms) was selectively decreased [43].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [43]
In mice with a gene-trap insertion in the first intron of Ppp2r4 (hypomorphic PTPA allele), embryonic lethality is suggested.
“-Embryonic lethality suggested; decreased overall survival in gt/+ mice [43]”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [43]
The spontaneous tumor phenotype in PTPA-deficient mice upon aging is less penetrant and mainly characterized by hematologic malignancies, less commonly HCC.
“The spontaneous tumor phenotype observed in PTPA-deficient mice upon aging, was somewhat less penetrant, and mainly characterized by the development of hematologic malignancies, and less commonly, of HCC.”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [43]
A prominent spontaneous cancer phenotype is observed in total-body constitutive B56δ knockout mice and in homozygous and heterozygous hypomorphic Ptpa mice.
“A very prominent spontaneous cancer phenotype was indeed observed in the total-body, constitutive KO model of the B56δ subunit [110] and in both homozygous and heterozygous mice of a hypomorphic Ptpa allele [43].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [43]
In PTPA-deficient mouse tumors, no common signaling defects are revealed, although sporadic activation of Wnt, Hedgehog, and c-Myc signaling is present in some tumor tissues.
“In this case, no common signaling defects could be revealed, although sporadic activation of Wnt signaling (increased β-catenin expression), Hedgehog signaling (increased Gli1 expression) and c-Myc activation (Ser62 phosphorylation) were present in some of the tumor tissues analyzed [43].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [43]
In Ppp2r4 gt/+ mice, DMBA/TPA-induced skin carcinogenesis is accelerated.
“-Accelerated DMBA/TPA-induced skin carcinogenesis in gt/+ mice”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [43]
In Ppp2r4 gt/+ and gt/gt mice older than 12 months, spontaneous cancer develops, mainly hematologic malignancies and less often HCC.
“-Spontaneous cancer development in gt/+ and gt/gt mice > 12 months: | mainly hematologic malignancies, less: HCC.”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [43]
In Ppp2r4 gt/gt tumors, Wnt, c-Myc and Hedgehog signaling are sporadically activated.
“-Sporadic activation of Wnt, c-Myc and Hedgehog signaling | in gt/gt tumors”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [43]
The Ppp2r4 gt allele lowers the activity of certain PP2A trimers, specifically B56-type but not B55.
“-Decreased activity of a selective set of PP2A trimers (B56-type, not | B55)”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [43]
The citation lists haven’t been fetched yet
References 58 · Cited by 42
- Authors
- Sents, W., Meeusen, B., Kalev, P., Radaelli, E., Sagaert, X., Miermans, E., Haesen, D., Lambrecht, C., Dewerchin, M., Carmeliet, P., Westermarck, J., Sablina, A., & Janssens, V.
- Affiliations
- KU Leuven (BE)
- VIB-KU Leuven Center for Cancer Biology (BE)
- Åbo Akademi University (FI)
- ORCID
- Venue
- Cancer Research
- Published
- 2017-12-14
- Volume
- 77
- Issue
- 24
- Pages
- 6825-6837
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2765105123
- Cited by
- 42
- References
- 58
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 7 · 2018: 7 · 2017: 3
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- protein phosphatase 2A, PTPA, haploinsufficiency, tumor suppressor, PP2A inhibition, spontaneous tumors, hematologic malignancies, hepatocellular carcinoma, c-Myc phosphorylation, Wnt signaling, Hedgehog signaling, skin carcinogenesis, lifespan reduction, null alleles
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Cells, Cultured, Enzyme Activation, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Neoplasms, Phosphoprotein Phosphatases, Genes, Tumor Suppressor, Mice, Protein Phosphatase 2, HEK293 Cells, Haploinsufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review